Research is being conducted on the role of Polycomb group proteins in cancer, including their function in regulating mammalian development and cell cycle control. Studies are exploring the therapeutic potential of targeting these proteins in various types of cancer, such as breast, lung, and other malignancies. The mechanisms of action and potential applications of Polycomb group proteins in cancer treatment are being investigated through various avenues, including the analysis of chromatin fragments and the regulation of 3D genome structure.